MSD To Sign Licensing Pacts With 5 Indian Drug Firms For Oral Drug Candidate For Covid-19
Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate molnupiravir, which is being studied for the treatment of Covid-19, with Indian drug…
Share